Dyspepsia and Chronic Gastritis by Yabluchansky, M. et al.
Supportive module 2: Basics of diagnosis, treatment  
and prevention of major gastroenterological diseases 
 
Dyspepsia and Chronic Gastritis 
 
LECTURE IN INTERNAL MEDICINE FOR IV COURSE STUDENTS 
M. Yabluchansky, L. Bogun, L. Martymianova, O. Bychkova, N. Lysenko, M. Brynza 
V.N. Karazin National University Medical School’  Internal Medicine Dept. 
 
Plan of the Lecture   
• Definition 
• Epidemiology 
• Mechanisms  
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• Clinical presentation 
• Diagnosis 




• Diagnostic guidelines 
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Definition: Dyspepsia 
Dyspepsia (Indigestion) is defined as one or more of 
the symptoms (Rome III criteria) : postprandial 
fullness (postprandial distress syndrome), early 
satiation  due to inability to finish a normal sized meal 
(postprandial distress syndrome) and epigastric pain 
or burning (epigastric pain syndrome).  
http://www.uptodate.com/contents/approach-to-the-adult-with-dyspepsia/abstract/1 
Epidemiology: Dyspepsia  1 
• Dyspepsia is a common problem worldwide 
• In the United States, the point prevalence is 
approximately 25%, excluding those people who 
have typical gastroesophageal reflux disease (GERD) 
symptoms 
• Approximately 9% of people who had no symptoms 
of dyspepsia annually in the prior year reported 
new symptoms on follow-up   
http://gi.org/guideline/management-of-dyspepsia/ 
Epidemiology: Dyspepsia  2 
• In Scandinavia, an incidence rate of less than 1% 
over 3 months has been reported 
• Whatever the incidence, the number of subjects 
who develop dyspepsia is matched by a similar 
number of subjects who lose their symptoms, 
explaining the observation that the prevalence 
remains stable. 
http://gi.org/guideline/management-of-dyspepsia/ 
Risk Factors: Dyspepsia  
• Female gender   
• Concomitant IBS   
• Unemployment   
• Alcohol 48   
• Smoking 44   
• NSAID 
IBS: irritable bowel syndrome  
NSAID: nonsteroidal anti-inflammatory drug  
kjim.org/upload//thumbnails/kjim-2016-091f1.gif hindawi.com/journals/grp/2012/562393/ 
Risk Factors: Dyspepsia 













• Theophylline Orlistat  
dealpain.net/wp-content/uploads/2016/03/oral-NSAIDs.jpg ncbi.nlm.nih.gov/pmc/articles/PMC3002574/ 
Etiology: Dyspepsia 1 
• Eating too much 
• Eating too rapidly 
• Consuming fatty or 
greasy foods 
• Consuming spicy foods 
• Consuming too much 
coffee 
• Consuming too much 
alcohol 
• Consuming too much 
chocolate 
• Consuming too many 
fizzy drinks 
• Emotional trauma 
• Gallstones 
http://www.medicalnewstoday.com/articles/163484.php 
Etiology: Dyspepsia 2 
• Gastritis 
• Hiatus hernia 
• Infection, especially 
with H pylori 
• Nervousness 
• Obesity   
• Pancreatitis 
• Peptic ulcers 
• Smoking 
• Some medications, 
such 
as antibiotics and NSA
IDs   
• Stomach cancer 
 
http://www.medicalnewstoday.com/articles/163484.php 
Etiology: Dyspepsia 3 
http://image.slidesharecdn.com/zagari2-140505092947-phpapp02/95/diagnosis-and-treatment-of-helicobacter-pylori-infection-7-638.jpg?cb=1399282359 
Endoscopic findings in individuals with dyspepsia 
in the Italian population 
Mechanisms: Dyspepsia 1 
• Patients may have abnormal motor function of the 
proximal stomach 
• Increased perception of physiological or minor 
noxious stimuli has been demonstrated in both the 
fasting and postprandial states  
http://gut.bmj.com/content/51/suppl_1/i63.full.pdf 
Mechanisms: Dyspepsia 2 
• Although gastric sensorimotor dysfunction is the 
main pathophysiological finding, the relationship 
and relevance of these disorders to symptoms is 
largely unknown 
• Studies attempting to identify a relation between H 
pylori infection and functional dyspepsia have 
yielded inconsistent and often confusing results. 
http://gut.bmj.com/content/51/suppl_1/i63.full.pdf 
Mechanisms: Dyspepsia 3 
http://image.slidesharecdn.com/dyspepsiajan15v1-150125101435-conversion-gate02/95/dyspepsia-an-evidence-based-approach-8-638.jpg?cb=1422202569 
Classification: Dyspepsia 1  
(International Classification of Diseases (ICD)) 1 
https://www.tsoshop.co.uk/productimages/default.aspx?ISBN=9789241549165&FORMAT=3  http://apps.who.int/classifications/icd10/browse/2016/en#/XI 
XI Diseases of the digestive 
system   
K30 Functional dyspepsia   
Classification: Dyspepsia 2 
 Rome III Diagnostic Criteria for Functional Dyspepsia 
 At least 3 months, with onset at least 6 months 
previously, of 1 or more of the following: 
• Bothersome postprandial fullness 
• Early satiation 
• Epigastric pain 
• Epigastric burning 
And 
• No evidence of structural disease (including at 
upper endoscopy) that is likely to explain the 
symptoms 
http://www.medscape.org/viewarticle/533460 
Classification: Dyspepsia 3 
 Rome III Diagnostic Criteria for Functional Dyspepsia 
At least 3 months, with onset at least 6 months 
previously, of 1 or more of the following: 
• Bothersome postprandial fullness 
• Early satiation 
• Epigastric pain 
• Epigastric burning 
And 
• No evidence of structural disease (including at 
upper endoscopy) that is likely to explain the 
symptoms 
http://www.medscape.org/viewarticle/533460 
Classification: Dyspepsia 4 
 Rome III Diagnostic Criteria for Epigastric Pain Syndrome 1 
At least 3 months, with onset at least 6 months 
previously, with ALL of the following: 
Pain and burning that is: 
• intermittent 
• localized to the epigastrium of at least moderate 
severity, at least once per week,  
http://www.medscape.org/viewarticle/533460 
Classification: Dyspepsia 5 
 Rome III Diagnostic Criteria for Epigastric Pain Syndrome 2 
At least 3 months, with onset at least 6 months 
previously, with ALL of the following: 
• and NOT: 
– generalized or localized to other abdominal or 
chest regions 
– relieved by defecation or flatulence 
– fulfilling criteria for gallbladder or sphincter of 
Oddi disorders 
http://www.medscape.org/viewarticle/533460 
Classification: Dyspepsia 6 
 Rome III Diagnostic Criteria for Postprandial Distress Syndrome 
At least 3 months, with onset at least 6 months 
previously, of 1 or more of the following: 
• Bothersome postprandial fullness 
1. occurring after ordinary-sized meals 
2. at least several times a week 
• Or 
• Early satiation 
1. that prevents finishing a regular meal 
2. and occurs at least several times a week. 
http://www.medscape.org/viewarticle/533460 
Signs and Symptoms: Dyspepsia 1 
• Most people feel pain and 
discomfort in the stomach 
or chest area generally 
soon after consuming food 
or drink, and in some cases 
during a meal or some time 
after a meal  
image.shutterstock.com/z/stock-photo-indigestion-or-dyspepsia-stomach-disease-sign-and-symptoms-403597576.jpg medicalnewstoday.com/articles/163484.php 
Signs and Symptoms: Dyspepsia 2 
• The following symptoms 
are also common: nausea, 
belching, feeling bloated 
(very full), vomiting, early 
satiety, and abdominal 
distention (swelling).  
image.shutterstock.com/z/stock-photo-indigestion-or-dyspepsia-stomach-disease-sign-and-symptoms-403597576.jpg medicalnewstoday.com/articles/163484.php 
History: Dyspepsia 1 
• A detailed history is necessary to narrow the 
differential diagnosis and to identify 
gastroesophageal reflux disease (GERD) and 
nonsteroidal anti-inflammatory drug (NSAID)-
induced dyspepsia, as well as patients with alarm   
• Radiation of the pain to the back or personal or 
family history of pancreatitis may be indicative of 
chronic pancreatitis   
http://www.uptodate.com/contents/approach-to-the-adult-with-dyspepsia 
History: Dyspepsia 2 
• Significant weight loss, anorexia, vomiting, 
dysphagia, odynophagia, and a family history of 
gastrointestinal cancers suggest the presence of an 
underlying malignancy  
• The presence of severe episodic epigastric or right 
upper quadrant abdominal pain lasting more than 
an hour or pain that occurs at any time is suggestive 
of symptomatic cholelithiasis.  
http://www.uptodate.com/contents/approach-to-the-adult-with-dyspepsia 
Physical Exam: Dyspepsia 1 
• The physical examination is usually normal, except 
for epigastric tenderness 
• The presence of epigastric tenderness cannot 
accurately distinguish organic dyspepsia from 
functional dyspepsia  
http://www.uptodate.com/contents/approach-to-the-adult-with-dyspepsia 
Physical Exam: Dyspepsia 2 
• Abdominal tenderness on palpation should be 
evaluated with the Carnett sign to determine if it is 
due to pain arising from the abdominal wall rather 
than due to inflammation of the underlying viscera: 
if the pain is decreased (negative Carnett’s sign), 
the origin of pain is not from the abdominal wall 
and likely from an intra-abdominal organ, as the 
tensed abdominal wall muscles protect the viscera.   
http://www.uptodate.com/contents/approach-to-the-adult-with-dyspepsia 
Complications: Dyspepsia 1 
• The complications are relatively limited 
• Since symptoms are most often provoked by eating, 
patients who alter their diets and reduce their 
intake of calories may lose weight 
• Symptoms that awaken patients from sleep are 
more likely to be due to non-functional than 
functional disease   
http://www.medicinenet.com/dyspepsia/page5.htm 
Complications: Dyspepsia 2 
• Most commonly, dyspepsia interfere with patients' 
comfort and daily activities 
• The interference with daily activities also can lead 
to problems with interpersonal relationships, 
especially with spouses 
• Most patients live with their symptoms and 
infrequently visit physicians for diagnosis and 
treatment. 
http://www.medicinenet.com/dyspepsia/page5.htm 
Red flags for people: Dyspepsia 1 
• Age 50 years or older at first presentation 
• Family history of gastric cancer with age of onset < 
50 years 
• Severe or persistent dyspepsia 
• Previous peptic ulcer disease, particularly if 
complicated 
• Ingestion of NSAIDs, including aspirin  
http://www.bpac.org.nz/BPJ/2011/february/dyspepsia.aspx 
Red flags for people: Dyspepsia 2 
• Signs and symptoms of chronic gastrointestinal 
bleeding 
• Iron deficiency anemia 
• Difficulty in swallowing 
• Persistent or protracted vomiting 
• Palpable abdominal mass 
• Coughing spells or nocturnal aspiration 
• Unexplained weight loss 
http://www.bpac.org.nz/BPJ/2011/february/dyspepsia.aspx 
Diagnosis: Dyspepsia 1 
• Dyspepsia is diagnosed on the basis of typical 
symptoms and the absence of other gastrointestinal 
diseases  
• Patients >55, or those with alarm features should 
undergo prompt endoscopy to rule out other 
gastrointestinal diseases   
http://gi.org/guideline/management-of-dyspepsia/ 
Diagnosis: Dyspepsia 2 
• In patients <55 with no alarm features, the clinician 
may consider two approximately equivalent 
management options: (i) test and treat for H. pylori 
using a validated noninvasive test and a trial of acid 
suppression if eradication is successful but 
symptoms do not resolve or (ii) an empiric trial of 
acid suppression with a proton pump inhibitor (PPI) 
for 4–8 wk.  
http://gi.org/guideline/management-of-dyspepsia/ 
Diagnosis: Dyspepsia 3 
• Repeat upper endoscopy (EGD) is not 
recommended once a firm diagnosis of functional 
dyspepsia has been made, unless completely new 
symptoms or alarm features develop.   
http://gi.org/guideline/management-of-dyspepsia/ 
Management: Dyspepsia 1 
• Diet and lifestyle changes (consuming less fatty 
foods, coffee, alcohol and chocolates; sleeping at 
least 7 hours every night; and avoiding spicy foods) 
• Antacids (over-the-counter, no prescription needed) 
• H-2-receptor antagonists  
• Proton pump inhibitors (PPIs)   
• Prokinetics (the efficacy has been questioned)   
 
http://www.medicalnewstoday.com/articles/163484.php?page=2 
Management: Dyspepsia 2 
• Antidepressants, if no causes for indigestion are 
found and the patient has not responded to 
treatments 
• Psychological treatments 
• Psychotherapy and behavioral therapy may also 





Schematic Diagram  
http://www.bpac.org.nz/BPJ/2011/february/dyspepsia.aspx 
Prognosis: Dyspepsia 
• Dyspepsia is not a disease, but rather a symptom of 
other diseases or disorders 
• Consequently, the predicted outcome ultimately 
depends on the underlying cause of the dyspeptic 
symptoms. 
http://www.mdguidelines.com/dyspepsia/prognosis 
 US MLE TEST 
https://www.medbullets.com/step1-endocrine/9019/pheochromocytoma 
Definition: Gastritis   
Gastritis is a result of inflammation, irritation, or 
erosion of the lining of the stomach that can occur 
suddenly (acute) or gradually (chronic) and clinically 
may manifest with symptoms  of  upper abdominal 
pain,  nausea , vomiting, bloating, loss of appetite 
and heartburn, sometimes with possible 
complications in forms of bleeding, stomach ulcers, 
and stomach tumors, etc. 
http://www.uptodate.com/contents/approach-to-the-adult-with-dyspepsia/abstract/1 
Epidemiology: Chronic Gastritis 1  
• An estimated 50% of the world population is 
infected with H pylori; consequently, chronic 
gastritis is extremely frequent 
• H pylori infection is highly prevalent in Asia and in 
developing countries, and multifocal atrophic 
gastritis and gastric adenocarcinomas are more 
prevalent in these areas   
http://emedicine.medscape.com/article/176156-overview 
Epidemiology: Chronic Gastritis 2  
• Autoimmune gastritis is a relatively rare disease, 
most frequently observed in individuals of northern 
European descent  and black people 
• The frequency of pernicious anemia is increased in 
patients with autoimmune gastritis and other 
immunologic diseases, including Graves disease, 
myxedema, thyroiditis, vitiligo and 
hypoparathyroidism. 
http://emedicine.medscape.com/article/176156-overview 
Risk Factors: Chronic Gastritis   
• African-American, 
Northern-European, 
Hispanic or Asian 
descent 
• Infection  
• Regular use of pain 
relievers   
• Older age 
• Excessive alcohol use  
• Smoking 
• Distress  
• Erosion   
• Bile reflux disease  
• Major surgery  
• Chronic autoimmune 
conditions  
images.medicinenet.com/images/appictures/gastritis-s3-causes.jpg www.mayoclinic.org/diseases-conditions/gastritis/basics/risk-factors/con-20021032 
Etiology: Chronic Gastritis 1   
• Chronic gastritis may be caused by either infectious 
or noninfectious conditions 
• Infectious forms include gastritis caused by H pylori 
and Helicobacter heilmannii infection; 
mycobacteriosis, syphilis, histoplasmosis, 
mucormycosis, South American blastomycosis, 
anisakiasis, or anisakidosis (granulomatous gastritis 
); Strongyloides species, schistosomiasis, 
or Diphyllobothrium latum (parasitic gastritis); viral 
(e.g., CMV or herpesvirus) infection, etc.   
http://emedicine.medscape.com/article/176156-overview 
Etiology: Chronic Gastritis 2   
• Noninfectious forms include autoimmune gastritis, 
chemical gastropathy (chronic bile reflux, NSAID and 
aspirin intake), uremic gastropathy, chronic 
noninfectious granulomatous gastritis (Crohn 
disease, sarcoidosis, Wegener granulomatosis, 
foreign bodies, cocaine use, rheumatoid nodules, 
gastric lymphoma), radiation injury to the stomach , 
etc.). 
http://emedicine.medscape.com/article/176156-overview 
Mechanisms: Chronic Gastritis 1  
• Chronic gastritis is a progressive, irreversible decay 
(atrophy) of the lining (gastric mucosa) and 
glandular tissue within the stomach 
• In some disorders the body targets the stomach as 
if it were a foreign protein or pathogen; it makes 
antibodies against, severely damages, and may even 
destroy the stomach or its lining  
http://www.mdguidelines.com/gastritis 
Mechanisms: Chronic Gastritis 2  
• In some cases bile, normally used to aid digestion in 
the small intestine, will enter through the pyloric 
valve of the stomach if it has been removed during 
surgery or does not work properly, also leading to 
gastritis 
• Since 1992, chronic gastritis lesions are classified 
according to the Sydney system. 
http://www.mdguidelines.com/gastritis 
Mechanisms: Chronic Gastritis   
H pylori and NSAID have synergistic effects on 
gastric mucosal damage.   
http://www.medscape.com/viewarticle/522900_2 
Mechanisms: Chronic Gastritis   
Natural history of H. pylori infection 
http://emedicine.medscape.com/article/176156-overview 
Classification: Chronic Gastritis 
(International Classification of Diseases (ICD)) 1 
https://www.tsoshop.co.uk/productimages/default.aspx?ISBN=9789241549165&FORMAT=3  http://apps.who.int/classifications/icd10/browse/2016/en#/XI 
XI Diseases of the digestive 
system    
K29 Gastritis and duodenitis 
• K29.3 Chronic superficial 
gastritis 
• K29.4 Chronic atrophic gastritis 
• K29.5 Chronic gastritis, 
unspecified  
Classification: Chronic Gastritis 1 
• There are follows forms of chronic gastritis: 
• Type A gastritis (autoimmune atrophic gastritis) 
may be triggered by a physical or psycho-
emotional stressor that causes the individual's 
immune system to produce antibodies against 
certain cells in the stomach (parietal cells); 
destruction of these cells results in atrophy of the 
stomach tissue  
http://www.mdguidelines.com/gastritis 
Classification: Chronic Gastritis 2 
• There are follows forms of chronic gastritis: 
• Type B gastritis (simple atrophic gastritis) is more 
common and is strongly associated with the 
presence of a certain bacterium (Helicobacter 
pylori) in the stomach mucosa 
• Type AB gastritis (environmental) 
• Chemical gastritis (reflux gastritis) 
• Uncommon forms  
http://www.mdguidelines.com/gastritis 
Classification: Chronic Gastritis 3 
The updated Sydney System: Classification and Grading of 








System   
http://www.intechopen.com/source/html/41544/media/image1.png 
Classification: Chronic Gastritis 4  
Operative Link for Gastritis Assessment (OLGA)  
http://www.scielo.org.co/scielo.php?pid=S0120-99572010000300011&script=sci_arttext&tlng=en 
Signs and Symptoms: Chronic Gastritis 1   
• Many people experience no symptoms at all 
• Upper central abdominal pain is the most common 
symptom; the pain may be dull, vague, burning, 
aching, gnawing, sore, or sharp; the pain is usually 
located in the upper central portion of 
the abdomen, but it may occur anywhere from the 
upper left portion of the abdomen around to the 
back   
https://en.wikipedia.org/wiki/Gastritis#cite_note-DS00488-20 
Signs and Symptoms: Chronic Gastritis 2   
• Other signs and symptoms may include nausea, 
vomiting (if present, may be clear, green or yellow, 
blood-streaked, or completely bloody, depending 
on the severity of the stomach inflammation), 
belching (if present, usually does not relieve the 
pain much), bloating, early satiety, loss of appetite, 
unexplained weight loss. 
https://en.wikipedia.org/wiki/Gastritis#cite_note-DS00488-20 
History: Chronic Gastritis 1 
• Patients may report vague stomach distress, a 
sensation of fullness, nausea, malaise, a heavy 
feeling in the stomach after meals, or ulcer-like 
symptoms 
• Symptoms typically occur within 1 to 5 hours after 
meals 
• With severe gastritis, the individual may also report 
chest pain, sweating, and feeling faint  
https://www.mdguidelines.com/gastritis 
History: Chronic Gastritis 2 
• There may be a history of ulcers, recent use of 
NSAIDs, recent ingestion of highly acidic food or 
chemicals, recent radiation or surgical procedure, or 
past gastrointestinal illness 
• Patients may report having eaten raw fish 
• Patients history should include information 
regarding eating, drinking, and smoking habits as 
well as prescription and nonprescription drug use. 
https://www.mdguidelines.com/gastritis 
Physical Exam: Chronic Gastritis 1  
• The exam results are most often normal  
• Rarely, there is abdominal tenderness, pale skin, 
tachycardia, dyspnea, or hypotension 
• Some findings are specifically associated with the 
particular complications of H pylori (associated 
gastritis and autoimmune gastritis)  
• If gastric ulcers coexist, guaiac-positive stool may 
result from occult blood loss  
http://emedicine.medscape.com/article/176156-clinical#b3 http://www.mdguidelines.com/gastritis 
Physical Exam: Chronic Gastritis 2  
• With severe cobalamin deficiency, the patient is 
pale and has slightly icteric skin and eyes  
• The individual may have foul-smelling breath 
(halitosis), with bloating associated with bacterial 
overgrowth syndrome. 
http://emedicine.medscape.com/article/176156-clinical#b3 http://www.mdguidelines.com/gastritis 
Complications: Chronic Gastritis   
• Although gastritis may not produce symptoms, its 
complications do 
• Left untreated, gastritis may lead to stomach ulcers 
and stomach bleeding, or even cancer of the 
stomach 
• Another potential complication is a severe loss of 
blood 
• Others include: intestinal metaplasia (the last stage 
of Barrett's esophagus), pernicious anemia caused 
by vitamin B12 insufficiency,  peptic ulcers,  
stomach cancer. 
http://ehealthforum.com/health/gastritis_symptoms-e664.html 
Diagnosis: Chronic Gastritis 1  
• The diagnosis may be established by a complete history and physical 
examination 
• Some cases may require blood tests and other tests (endoscopy) or 
a consultation with a specialist (usually a gastroenterologist) 
• The tests which may be used to verify gastritis include: evaluation 
for H. pylori by way of blood, breath or stool testing; blood cell 
counts (looking for anemia); liver and kidney functions, urinalysis, 
gallbladder and pancreas functions; pregnancy test; stool test 
(looking for blood); X-rays (an upper gastrointestinal series or 
a barium swallow); an electrocardiogram (ECG, EKG),  endoscopy, 
stomach biopsy. 
https://en.wikipedia.org/wiki/Gastritis#Diagnosis 
Diagnosis: Chronic Gastritis 2  
http://gastritis-blog.blogspot.com/ 
Management: Chronic Gastritis 
Approach Considerations 1 
• Treatment can be aimed at a specific etiologic 
agent, if such an agent is known 
• When gastritis represents gastric involvement of a 
systemic disease, treatment is directed toward the 
primary disease  
• Some entities manifested by chronic gastritis do not 
have well-established treatment protocols  
http://emedicine.medscape.com/article/176156-treatment#showall 
Management: Chronic Gastritis 
Approach Considerations 2 
• For example, in lymphocytic gastritis, some cases of 
spontaneous healing have been reported, however, 
because the disease has a chronic course, 
treatment is recommended (some studies have 
reported successful treatment of exudative 
lymphocytic gastritis with omeprazole). 
http://emedicine.medscape.com/article/176156-treatment#showall 
Management: Chronic Gastritis 
Pharmacotherapy for H pylori 1 
 
• If H pylori is identified as the underlying cause of 
gastritis, it should be eradicated  
• Antibiotics that have proven effective against H 
pylori include clarithromycin, amoxicillin, 
metronidazole, tetracycline, and furazolidone 
• Cure rates with single antibiotics have been poor (0-
35%), that's why five regimens are approved by the 
US Food and Drug Administration (FDA) for the 
treatment of H pylori infection  
http://emedicine.medscape.com/article/176156-treatment#showall 
Management: Chronic Gastritis 
Pharmacotherapy for H pylori 2 
 
• The most effective of these regimens is bismuth-
metronidazole-tetracycline (BMT) triple therapy, 
followed by ranitidine bismuth citrate plus 
clarithromycin and then by omeprazole plus 
clarithromycin. 
• Quadruple therapies are recommended as second-
line treatment when triple therapies fail.    
http://emedicine.medscape.com/article/176156-treatment#showall 
Management: Chronic Gastritis 
Triple and  Quadruple Pharmacotherapy for H pylori 1 
Triple therapies (with indicated adult dosing): 
• Lansoprazole 30 mg, omeprazole 20 mg, or 
ranitidine bismuth citrate 400 mg orally twice daily 
• Clarithromycin 500 mg orally twice daily 
• Amoxicillin 1000 mg or metronidazole 500 mg orally 
twice daily  
http://emedicine.medscape.com/article/176156-treatment#showall 
Management: Chronic Gastritis 
Triple and  Quadruple Pharmacotherapy for H pylori 2 
 
Quadruple therapies (with indicated adult dosing): 
• lansoprazole 30 mg or omeprazole 20 mg orally 
twice daily 
• Tetracycline HCl 500 mg orally 4 times daily 
• Bismuth subsalicylate 120 mg orally 4 times daily 
• Metronidazole 500 mg orally 3 times daily 
http://emedicine.medscape.com/article/176156-treatment#showall 
Management: Chronic Gastritis 
Long-Term Monitoring Pharmacotherapy for H pylori 1 
• If a patient was treated for H pylori infection, 
confirm that the organism has been eradicated 
• Evaluate eradication at least 4 weeks after the 
beginning of treatment. 
• Eradication may be assessed by means of 
noninvasive methods such as the urea breath test 
or the stool antigen test   
http://emedicine.medscape.com/article/176156-treatment#showall 
Management: Chronic Gastritis 
Long-Term Monitoring Pharmacotherapy for H pylori 2 
• Follow-up may be individualized, depending on 
findings during endoscopy (for example, if dysplasia 
is found at endoscopy, increased surveillance is 
necessary) 
•  For patients with atrophic gastritis or dysplasia, 
follow-up endoscopy is recommended after 6 
months. 
http://emedicine.medscape.com/article/176156-treatment#showall 
Prognosis: Chronic Gastritis 1  
• The prognosis is strongly related to the underlying 
cause 
• Chronic gastritis may progress asymptomatically in 
some patients, whereas other patients report 
dyspeptic symptoms  
• The clinical course may be worsened when patients 
develop any of the possible complications of H 
pylori infection, such as peptic ulcer or gastric 
malignancy    
http://emedicine.medscape.com/article/176156-overview#a7 
Prognosis: Chronic Gastritis 2 
• Eradication of H pylori results in rapid cure of the 
infection with disappearance of the inflammatory 
infiltration of the gastric mucosa   
• In patients with autoimmune gastritis, the major 
effects are consequent to the loss of parietal and 
chief cells and include achlorhydria, 
hypergastrinemia, loss of pepsin and pepsinogen, 
anemia, and an increased risk of gastric neoplasms . 
http://emedicine.medscape.com/article/176156-overview#a7 
Prophylaxis Dyspepsia and Gastritis 
• Prevention is by avoiding things that cause 
dyspepsia and gastritis 
• Proper hygiene, hand washing, and eating and 
drinking only adequately cleaned or treated foods 
and fluids are first healthy ways to decrease risk of 




ECG, EKG - electrocardiogram  
EGD - upper endoscopy 
FDA - Food and Drug Administration 
GERD - gastroesophageal reflux disease 
IBS - irritable bowel syndrome   
NSAIDs – nonsteroidal anti-inflammatory drugs 
PPI - proton pump inhibitor  
 
Diagnostic and treatment guidelines 
• Approach to the adult with dyspepsia 
• Evaluation and management of dyspepsia 
• Evidence-based clinical practice guidelines for functional dyspepsia 
• Gastritis 
• Kyoto global consensus report on Helicobacter pylori gastritis 
• Management of Dyspepsia 
• Management of Helicobacter pylori infection the Maastricht IV/ 
Florence Consensus Report 
